These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

867 related items for PubMed ID: 26220125

  • 1. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence.
    Zhang NN, Lu W, Cheng XJ, Liu JY, Zhou YH, Li F.
    Clin Radiol; 2015 Nov; 70(11):1237-43. PubMed ID: 26220125
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma.
    Ding J, Jing X, Liu J, Wang Y, Wang F, Wang Y, Du Z.
    Eur J Radiol; 2013 Sep; 82(9):1379-84. PubMed ID: 23726122
    [Abstract] [Full Text] [Related]

  • 6. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY, Xie XY, Lu MD, Xu HX, Xu ZF, Kuang M, Liu GJ, Liang JY, Lau WY.
    Cancer; 2009 May 01; 115(9):1914-23. PubMed ID: 19241423
    [Abstract] [Full Text] [Related]

  • 7. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice.
    Chinnaratha MA, Sathananthan D, Pateria P, Tse E, MacQuillan G, Mosel L, Pathi R, Madigan D, Wigg AJ.
    Eur J Gastroenterol Hepatol; 2015 Mar 01; 27(3):349-54. PubMed ID: 25563141
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Sohn W, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    Scand J Gastroenterol; 2014 Mar 01; 49(3):373-80. PubMed ID: 24354931
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment efficacy of CT-guided percutaneous microwave ablation for primary hepatocellular carcinoma.
    Yin T, Li W, Zhao P, Wang Y, Zheng J.
    Clin Radiol; 2017 Feb 01; 72(2):136-140. PubMed ID: 27890422
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis.
    Abdelaziz AO, Nabeel MM, Elbaz TM, Shousha HI, Hassan EM, Mahmoud SH, Rashed NA, Ibrahim MM, Abdelmaksoud AH.
    Scand J Gastroenterol; 2015 Apr 01; 50(4):479-84. PubMed ID: 25592058
    [Abstract] [Full Text] [Related]

  • 16. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma.
    Medhat E, Abdel Aziz A, Nabeel M, Elbaz T, Zakaria Z, Shousha H, Amer A, Fouad Fathalah W, Maher R, Musa S.
    J Dig Dis; 2015 Aug 01; 16(8):456-63. PubMed ID: 25958973
    [Abstract] [Full Text] [Related]

  • 17. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep 01; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.